1887
Preview this article:
Zoom in
Zoomout

Penicillin/ampicillin efficacy among children with severe pneumonia due to penicillin-resistant pneumococcus (MIC=4 μg ml), Page 1 of 1

| /docserver/preview/fulltext/jmm/58/10/1390-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.007765-0
2009-10-01
2019-11-15
Loading full text...

Full text loading...

/deliver/fulltext/jmm/58/10/1390.html?itemId=/content/journal/jmm/10.1099/jmm.0.007765-0&mimeType=html&fmt=ahah

References

  1. Aguado-García, J. M., Martín-Herrero, J. E. & Lumbreras-Bermejo, C. ( 2004; ). Bacterial resistance and pharmacodynamics as the basis for prescribing antibiotics in respiratory infections. Enferm Infecc Microbiol Clin 22, 230–237.[CrossRef]
    [Google Scholar]
  2. Ayieko, P. & English, M. ( 2007; ). Case management of childhood pneumonia in developing countries. Pediatr Infect Dis J 26, 432–440.[CrossRef]
    [Google Scholar]
  3. Cardoso, M. R. A., Nascimento-Carvalho, C. M., Ferrero, F., Berezin, E. N., Ruvinsky, R., Camargos, P. A. M., Sant'anna, C. C., Brandileone, M. C. C., March, M.-F. P. & other authors ( 2008; ). Penicillin resistant pneumococcus and risk of treatment failure in pneumonia. Arch Dis Child 93, 221–225.[CrossRef]
    [Google Scholar]
  4. CLSI ( 2007; ). Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. Document M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute.
  5. CLSI ( 2008; ). Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement. Document M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute.
  6. Dagan, R. ( 2003; ). Achieving bacterial eradication using pharmacokinetic/pharmacodynamic principles. Int J Infect Dis 7 (Suppl. 1), S21–S26.[CrossRef]
    [Google Scholar]
  7. Facklam, R. R. & Washington, J. A. ( 1991; ). Streptococcus and related catalase-negative Gram positive cocci. In Manual of Clinical Microbiology, 5th edn, pp. 238–257. Edited by A. Balows, W. J. Hausler, Jr, K. L. Hermann, H. D. Isenberg & H. J. Shadomy. Washington, DC: American Society for Microbiology.
  8. Heffelfinger, J. D., Dowell, S. F., Jorgensen, J. H., Klugman, K. P., Mabry, L. R., Musher, D. M., Plouffe, J. F., Rakowsky, A., Schucht, A. & other authors ( 2000; ). Management of community-acquired pneumonia in the era of pneumococcal resistance. Arch Intern Med 160, 1399–1408.[CrossRef]
    [Google Scholar]
  9. Jacobs, M. R. ( 2003; ). How can we predict bacterial eradication? Int J Infect Dis 7 (Suppl. 1), S13–S20.[CrossRef]
    [Google Scholar]
  10. Rothermel, C. D. ( 2004; ). Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes? Clin Infect Dis 38 (Suppl. 4), S346–S349.
    [Google Scholar]
  11. Sinaniotis, C. A. & Sinaniotis, A. C. ( 2005; ). Community-acquired pneumonia in children. Curr Opin Pulm Med 11, 218–225.[CrossRef]
    [Google Scholar]
  12. WHO ( 1990; ). ARI in Children: Case Management in Small Hospitals in Developing Countries. A Manual for Doctors and Other Senior Health Workers. Programme for the Control of ARI. Geneva: World Health Organization.
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.007765-0
Loading
/content/journal/jmm/10.1099/jmm.0.007765-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error